State

Listings in California

8 listings serving California. Compare fees, capabilities and credentials.

Hemp delta-9 edibles
Banned
since Jan 1, 2026 · AB 8 (Ch. 248, Stats. 2025); 17 CCR 23000 et seq. (DPH-24-005); B&P Code 26000.5(b)
THC drinks
Banned
since Sep 24, 2024 · 17 CCR 23000 et seq.; AB 8
THCA flower & pre-rolls
Banned
since Jan 1, 2026 · H&S Code 11018.5; B&P Code 26070.2(c) (AB 8)
Delta-8 & converted cannabinoids
Banned
since Jan 1, 2026 · B&P Code 26070.2, 26001 (AB 8); 17 CCR 23010 (DPH-24-005B)
Lab-made cannabinoids
Banned
since Jan 1, 2026 · B&P Code 26070.2(d) (AB 8); 17 CCR 23010 (DPH-24-005B)
Vapes & cartridges
Banned
since Jan 1, 2026 · B&P Code 26070.2(b) (AB 8)
CBD (≤0.4 mg THC per container)
Banned
since Sep 24, 2024 · 17 CCR 23000 et seq. (DPH-24-005); AB 8

Product class	Status	Channel	Caps	Min age	Effective	Next change	Statute	Checked
Hemp delta-9 edibles	Banned	No lawful retail channel	No detectable THC	—	Jan 1, 2026	Jan 1, 2028	AB 8 (Ch. 248, Stats. 2025); 17 CCR 23000 et seq. (DPH-24-005); B&P Code 26000.5(b)	Oct 8, 2026
THC drinks	Banned	No lawful retail channel	No detectable THC	—	Sep 24, 2024	Jan 1, 2028	17 CCR 23000 et seq.; AB 8	Oct 8, 2026
THCA flower & pre-rolls	Banned	No lawful retail channel	—	—	Jan 1, 2026	—	H&S Code 11018.5; B&P Code 26070.2(c) (AB 8)	Oct 8, 2026
Delta-8 & converted cannabinoids	Banned	No lawful retail channel	—	—	Jan 1, 2026	—	B&P Code 26070.2, 26001 (AB 8); 17 CCR 23010 (DPH-24-005B)	Oct 8, 2026
Lab-made cannabinoids	Banned	No lawful retail channel	—	—	Jan 1, 2026	—	B&P Code 26070.2(d) (AB 8); 17 CCR 23010 (DPH-24-005B)	Oct 8, 2026
Vapes & cartridges	Banned	No lawful retail channel	—	—	Jan 1, 2026	—	B&P Code 26070.2(b) (AB 8)	Oct 8, 2026
CBD (≤0.4 mg THC per container)	Banned	No lawful retail channel	No detectable THC	—	Sep 24, 2024	—	17 CCR 23000 et seq. (DPH-24-005); AB 8	Oct 8, 2026

As of Oct 10, 2026. Every row names its statute and the day we checked it. Grey rows are on the verification queue. Not legal advice.

Dates and deadlines that apply

Full timeline →

Dec 11, 2026 · Effective · US
Federal: total THC incl. THCA, 0.4 mg per container, converted delta-8
H.R. 6500 (signed Sep 2, 2026) provides that until Dec 11, 2026 the §781 amendments apply only to non-natural-cannabinoid products. So from Dec 11, 2026 the rest applies: hemp means total THC including THCA at 0.3% or less by dry weight; final products above 0.4 mg combined total THC per container are excluded; cannabinoids the plant can make but that were synthesized or manufactured outside it (commercial delta-8 converted from CBD) are excluded. DEA separately holds that chemically converted THCs are already Schedule I (91 FR 23913).
P.L. 119-103 (H.R. 6500), Div. B §2019 'Section 781 Extension'; P.L. 119-37 §781 · H.R. 6500 enrolled text = P.L. 119-103, approved Sep 2, 2026 (govinfo) · verified Oct 8, 2026
Dec 11, 2026 · Deadline · US
Federal funding bill expires
The Continuing Appropriations and Extensions Act, 2027 funds the government through Dec 11, 2026, the same day the rest of the hemp redefinition takes effect. The next spending bill is the most likely vehicle for any further change to the hemp dates; the OMB letter of Jun 24, 2026 asked Congress for 'at minimum, an extension' of §781's implementation.
Scheduled; may move — Dec 11 is also the continuing-resolution expiry and the OMB letter of Jun 24, 2026 asked Congress for 'at minimum, an extension'
P.L. 119-103 (H.R. 6500), Div. A §106(3) · H.R. 6500 enrolled text, Div. A §106 (govinfo); OMB letter Jun 24, 2026 · verified Oct 8, 2026
Nov 12, 2026 · Effective · US
Federal: cannabinoids the plant cannot make leave the hemp definition
From Nov 12, 2026 (365 days after enactment) intermediate and final hemp-derived cannabinoid products containing cannabinoids 'not capable of being naturally produced by a Cannabis sativa L. plant' (subclauses (1)(C)(ii)(I) and (iv)(I)) are no longer hemp and fall under the Controlled Substances Act. Until Dec 11, 2026 this is the only part of §781 that applies. On Oct 8, 2026 we found no FDA list that names which cannabinoids qualify (a dated search; see the row on FDA's lists).
P.L. 119-37, Div. B §781 (7 U.S.C. 1639o note), as limited by P.L. 119-103, Div. B §2019 · P.L. 119-37 (govinfo); P.L. 119-103, Div. B §2019 (govinfo) · verified Oct 8, 2026